{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Benzopyrene hydroxylase : Questions médicales les plus fréquentes",
"headline": "Benzopyrene hydroxylase : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Benzopyrene hydroxylase : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-05",
"dateModified": "2025-03-31",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Benzopyrene hydroxylase"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Aryl hydrocarbon hydroxylases",
"url": "https://questionsmedicales.fr/mesh/D001189",
"about": {
"@type": "MedicalCondition",
"name": "Aryl hydrocarbon hydroxylases",
"code": {
"@type": "MedicalCode",
"code": "D001189",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.422.220.453.010"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Benzopyrene hydroxylase",
"alternateName": "Benzopyrene Hydroxylase",
"code": {
"@type": "MedicalCode",
"code": "D001579",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Christopher J Schofield",
"url": "https://questionsmedicales.fr/author/Christopher%20J%20Schofield",
"affiliation": {
"@type": "Organization",
"name": "Chemistry Research Laboratory, Department of Chemistry, University of Oxford, 12 Mansfield Road, Oxford OX1 3TA, United Kingdom. Electronic address: Christopher.Schofield@chem.ox.ac.uk."
}
},
{
"@type": "Person",
"name": "Lei Wang",
"url": "https://questionsmedicales.fr/author/Lei%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Department of Economic Plants and Biotechnology, Yunnan Key Laboratory for Wild Plant Resources, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, 650201, China."
}
},
{
"@type": "Person",
"name": "Giorgia Fiorini",
"url": "https://questionsmedicales.fr/author/Giorgia%20Fiorini",
"affiliation": {
"@type": "Organization",
"name": "Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, 12 Mansfield Road, Department of Chemistry, University of Oxford, Oxford, OX1 3TA, United Kingdom."
}
},
{
"@type": "Person",
"name": "Doug N Halligan",
"url": "https://questionsmedicales.fr/author/Doug%20N%20Halligan",
"affiliation": {
"@type": "Organization",
"name": "School of Medicine, Systems Biology Ireland and the Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland."
}
},
{
"@type": "Person",
"name": "Cormac T Taylor",
"url": "https://questionsmedicales.fr/author/Cormac%20T%20Taylor",
"affiliation": {
"@type": "Organization",
"name": "School of Medicine, Systems Biology Ireland and the Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "11β Hydroxylase Deficiency in a Child with Hypothyroidism: A Case Report.",
"datePublished": "2023-12-01",
"url": "https://questionsmedicales.fr/article/38289749",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.31729/jnma.8378"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effects of hypoxia-inducible factor-prolyl hydroxylase inhibitors",
"datePublished": "2023-03-16",
"url": "https://questionsmedicales.fr/article/37008953",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fendo.2023.1131516"
}
},
{
"@type": "ScholarlyArticle",
"name": "Genotype-phenotype correlation in patients with 21-hydroxylase deficiency.",
"datePublished": "2023-03-13",
"url": "https://questionsmedicales.fr/article/36992809",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fendo.2023.1095719"
}
},
{
"@type": "ScholarlyArticle",
"name": "Characterization of phenylalanine hydroxylase gene variants and analysis of genotype-phenotype correlation in patients with phenylalanine hydroxylase deficiency from Fujian Province, Southeastern China.",
"datePublished": "2022-09-14",
"url": "https://questionsmedicales.fr/article/36104584",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11033-022-07579-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Human prolyl hydroxylase domain 2 reacts with O",
"datePublished": "2024-10-30",
"url": "https://questionsmedicales.fr/article/39478091",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-75761-y"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hémoprotéines",
"item": "https://questionsmedicales.fr/mesh/D006420"
},
{
"@type": "ListItem",
"position": 5,
"name": "Cytochromes",
"item": "https://questionsmedicales.fr/mesh/D003580"
},
{
"@type": "ListItem",
"position": 6,
"name": "Cytochrome P-450 enzyme system",
"item": "https://questionsmedicales.fr/mesh/D003577"
},
{
"@type": "ListItem",
"position": 7,
"name": "Aryl hydrocarbon hydroxylases",
"item": "https://questionsmedicales.fr/mesh/D001189"
},
{
"@type": "ListItem",
"position": 8,
"name": "Benzopyrene hydroxylase",
"item": "https://questionsmedicales.fr/mesh/D001579"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Benzopyrene hydroxylase - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Benzopyrene hydroxylase",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Benzopyrene hydroxylase",
"description": "Comment diagnostiquer une activité anormale de la benzopyrène hydroxylase ?\nQuels tests sont utilisés pour mesurer l'activité enzymatique ?\nY a-t-il des biomarqueurs associés à la benzopyrène hydroxylase ?\nQuels symptômes peuvent indiquer un dysfonctionnement enzymatique ?\nComment évaluer l'exposition au benzopyrène ?",
"url": "https://questionsmedicales.fr/mesh/D001579?page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Benzopyrene hydroxylase",
"description": "Quels sont les symptômes d'une exposition au benzopyrène ?\nL'exposition au benzopyrène peut-elle causer des cancers ?\nQuels signes cliniques sont associés à une intoxication ?\nPeut-on observer des effets à long terme ?\nQuels tests peuvent révéler des symptômes d'exposition ?",
"url": "https://questionsmedicales.fr/mesh/D001579?page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Benzopyrene hydroxylase",
"description": "Comment prévenir l'exposition au benzopyrène ?\nQuelles mesures de sécurité peuvent être prises ?\nL'alimentation peut-elle réduire les risques ?\nY a-t-il des vaccinations contre les effets du benzopyrène ?\nComment sensibiliser le public aux dangers ?",
"url": "https://questionsmedicales.fr/mesh/D001579?page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Benzopyrene hydroxylase",
"description": "Quel traitement est recommandé en cas d'intoxication au benzopyrène ?\nY a-t-il des antidotes pour le benzopyrène ?\nComment gérer les effets à long terme de l'exposition ?\nDes thérapies alternatives sont-elles efficaces ?\nQuels médicaments peuvent aider à réduire les symptômes ?",
"url": "https://questionsmedicales.fr/mesh/D001579?page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Benzopyrene hydroxylase",
"description": "Quelles complications peuvent survenir après exposition ?\nL'exposition prolongée augmente-t-elle les risques ?\nQuels types de cancers sont liés au benzopyrène ?\nDes effets sur la reproduction sont-ils possibles ?\nComment surveiller les complications potentielles ?",
"url": "https://questionsmedicales.fr/mesh/D001579?page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Benzopyrene hydroxylase",
"description": "Quels sont les principaux facteurs de risque d'exposition ?\nL'environnement joue-t-il un rôle dans l'exposition ?\nLes habitudes alimentaires influencent-elles le risque ?\nLes antécédents familiaux augmentent-ils le risque ?\nLes conditions de travail peuvent-elles influencer l'exposition ?",
"url": "https://questionsmedicales.fr/mesh/D001579?page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une activité anormale de la benzopyrène hydroxylase ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests enzymatiques et des analyses de sang peuvent évaluer l'activité de l'enzyme."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour mesurer l'activité enzymatique ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de métabolisme in vitro et des dosages enzymatiques spécifiques sont utilisés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des biomarqueurs associés à la benzopyrène hydroxylase ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des métabolites du benzopyrène peuvent servir de biomarqueurs dans les analyses."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un dysfonctionnement enzymatique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes liés à l'exposition aux toxines, comme des troubles respiratoires, peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'exposition au benzopyrène ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests d'urine et de sang peuvent mesurer les niveaux de benzopyrène et ses métabolites."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une exposition au benzopyrène ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des irritations respiratoires, des nausées et des maux de tête."
}
},
{
"@type": "Question",
"name": "L'exposition au benzopyrène peut-elle causer des cancers ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le benzopyrène est un cancérigène connu, lié à divers types de cancer."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont associés à une intoxication ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des troubles cutanés, des douleurs abdominales et des troubles neurologiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Peut-on observer des effets à long terme ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets chroniques comme des maladies pulmonaires et des cancers peuvent se développer."
}
},
{
"@type": "Question",
"name": "Quels tests peuvent révéler des symptômes d'exposition ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des examens d'imagerie peuvent aider à identifier des symptômes d'exposition."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition au benzopyrène ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les zones polluées et réduire l'exposition à la fumée de tabac et aux hydrocarbures."
}
},
{
"@type": "Question",
"name": "Quelles mesures de sécurité peuvent être prises ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des équipements de protection individuelle lors de la manipulation de substances toxiques."
}
},
{
"@type": "Question",
"name": "L'alimentation peut-elle réduire les risques ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en antioxydants peut aider à réduire les effets nocifs des toxines."
}
},
{
"@type": "Question",
"name": "Y a-t-il des vaccinations contre les effets du benzopyrène ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Aucune vaccination spécifique n'existe pour prévenir les effets du benzopyrène."
}
},
{
"@type": "Question",
"name": "Comment sensibiliser le public aux dangers ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des campagnes d'information et des programmes éducatifs peuvent sensibiliser aux risques d'exposition."
}
},
{
"@type": "Question",
"name": "Quel traitement est recommandé en cas d'intoxication au benzopyrène ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement consiste à éliminer l'exposition et à gérer les symptômes cliniques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des antidotes pour le benzopyrène ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas d'antidote spécifique, le traitement est symptomatique et de soutien."
}
},
{
"@type": "Question",
"name": "Comment gérer les effets à long terme de l'exposition ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et des traitements ciblés pour les maladies associées sont nécessaires."
}
},
{
"@type": "Question",
"name": "Des thérapies alternatives sont-elles efficaces ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines thérapies complémentaires peuvent aider à soulager les symptômes, mais peu de preuves existent."
}
},
{
"@type": "Question",
"name": "Quels médicaments peuvent aider à réduire les symptômes ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anti-inflammatoires et des antihistaminiques peuvent être utilisés pour soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après exposition ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des cancers, des maladies respiratoires et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "L'exposition prolongée augmente-t-elle les risques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une exposition prolongée au benzopyrène augmente significativement le risque de cancer."
}
},
{
"@type": "Question",
"name": "Quels types de cancers sont liés au benzopyrène ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le cancer du poumon, de la peau et de la vessie sont souvent associés à l'exposition au benzopyrène."
}
},
{
"@type": "Question",
"name": "Des effets sur la reproduction sont-ils possibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition au benzopyrène peut affecter la fertilité et le développement fœtal."
}
},
{
"@type": "Question",
"name": "Comment surveiller les complications potentielles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens médicaux réguliers et des tests de dépistage peuvent aider à surveiller les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'exposition ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les fumeurs, les travailleurs des industries pétrolières et ceux vivant près de routes polluées sont à risque."
}
},
{
"@type": "Question",
"name": "L'environnement joue-t-il un rôle dans l'exposition ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la pollution de l'air et les sites industriels augmentent le risque d'exposition au benzopyrène."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en viandes grillées peut augmenter l'exposition au benzopyrène."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux augmentent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de cancer peuvent augmenter la susceptibilité aux effets du benzopyrène."
}
},
{
"@type": "Question",
"name": "Les conditions de travail peuvent-elles influencer l'exposition ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines professions exposent davantage au benzopyrène, comme celles liées à la chimie et à l'industrie pétrolière."
}
}
]
}
]
}
Congenital adrenal hyperplasia occurs due to enzymatic defects in the adrenocortical steroidogenesis. 11β hydroxylase deficiency is the second most common cause of congenital adrenal hyperplasia which...
case reports; congenital adrenal hyperplasia; hypertension; hypothyroidism....
To compare the effects of five hypoxia-inducible factor-prolyl hydroxylase domain inhibitors (HIF-PHIs), two erythropoiesis-stimulating agents (ESAs), and placebo on iron metabolism in renal anemia pa...
Five electronic databases were searched for studies. Randomized controlled clinical trials comparing HIF-PHIs, ESAs, and placebo in NDD-CKD patients were selected. The statistical program used for net...
Of 1,589 original titles screened, data were extracted from 15 trials (3,228 participants). All HIF-PHIs and ESAs showed greater Hb level-raising ability than placebo. Among them, desidustat demonstra...
For NDD-CKD patients, HIF-PHIs could ameliorate functional iron deficiency by promoting iron transport and utilization, which may be achieved by decreasing hepcidin levels. Interestingly, HIF-PHIs had...
https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=242777, Identifier CRD42021242777....
21-hydroxylase deficiency (21OHD) is the most common cause of congenital adrenal hyperplasia (CAH). However, patients with 21OHD manifest various phenotypes due to a wide-spectrum residual enzyme acti...
A total of 15 individuals from three unrelated families were included in this study. Target Capture-Based Deep Sequencing and Restriction Fragment Length Polymorphism was conducted on peripheral blood...
Dramatically different phenotypes were seen in the three probands of CAH with different compound heterozygous mutations in CYP21A2. Proband 1 manifested simple virilizing with mutations of 30-kb delet...
Both gender and mutations contribute to the phenotypes, and patients with the same compound mutations and gender could present with different phenotypes. Genetic analysis could help the etiologic diag...
Phenylalanine hydroxylase deficiency (PAHD) is the most prevalent inherited disorder of amino acid metabolism in China. Its complex phenotype includes many variants and genotypes among different popul...
In this study, we analyzed the phenylalanine hydroxylase gene (PAH) variants in a cohort of 93 PAHD patients from Fujian Province. We also assessed genotype and phenotype correlation in patients with ...
Our study identified a PAH variant spectrum in PAHD patients from Fujian Province, Southeastern China. Quantitative correlation analysis between genotype and phenotype severity is helpful for genetic ...
Enzyme promiscuity is evolutionarily advantageous to plants for gaining new enzyme functions when adapting to environmental challenges. However, this promiscuity can negatively affect the expression o...
L-3,4-dihydroxyphenylalanine (L-DOPA) is in high demand as the cornerstone for treatment of Parkinson's disease. The current production of L-DOPA is associated with poor productivity and long producti...
17α-Hydroxylase deficiency is a very rare disease reported to be associated with a risk of gonadal malignancy. We herein report a rare case of seminoma in a 46, XY patient with 17α-hydroxylase deficie...
A 52-year-old woman presented with a 9-cm pelvic tumor. At age 14, she had been identified as having the XY karyotype and 17α-hydroxylase deficiency. However, she was not informed and did not consult ...
This is the third reported case of testicular tumor and the first of germ cell tumor in a 46, XY patient with 17α-hydroxylase deficiency. Given the rarity and the risk of gonadal malignancy associated...
The white-rot fungus Phanerochaete chrysosporium can degrade lignin polymers using extracellular, non-specific, one-electron oxidizing enzymes. This results in the formation of guaiacyl (G), syringyl ...
Tyrosine hydroxylase catalyzes the initial and rate-limiting step in the biosynthesis of the neurotransmitter dopamine. The phosphorylation state of Ser40 and Ser31 is believed to exert a direct effec...